BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 22518863)

  • 1. Comparison of the Abbott RealTime High-Risk Human Papillomavirus (HPV), Roche Cobas HPV, and Hybrid Capture 2 assays to direct sequencing and genotyping of HPV DNA.
    Park Y; Lee E; Choi J; Jeong S; Kim HS
    J Clin Microbiol; 2012 Jul; 50(7):2359-65. PubMed ID: 22518863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a multiplex real time PCR assay for the detection of human papillomavirus infections on self-collected cervicovaginal lavage samples.
    Jentschke M; Soergel P; Hillemanns P
    J Virol Methods; 2013 Oct; 193(1):131-4. PubMed ID: 23707925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Abbott RealTime High-Risk HPV and Hybrid Capture 2 Assays for Detection of HPV Infection.
    Ko K; Yu S; Lee EH; Park H; Woo HY; Kwon MJ
    Ann Clin Lab Sci; 2016 Sep; 46(5):522-8. PubMed ID: 27650620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of clinical performances among Roche Cobas HPV, RFMP HPV PapilloTyper and Hybrid Capture 2 assays for detection of high-risk types of human papillomavirus.
    Yu S; Kwon MJ; Lee EH; Park H; Woo HY
    J Med Virol; 2015 Sep; 87(9):1587-93. PubMed ID: 25914215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analytical evaluation of the PapilloCheck test, a new commercial DNA chip for detection and genotyping of human papillomavirus.
    Dalstein V; Merlin S; Bali C; Saunier M; Dachez R; Ronsin C
    J Virol Methods; 2009 Mar; 156(1-2):77-83. PubMed ID: 19041893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An HPV 16, 18, and 45 genotyping test based on Hybrid Capture technology.
    Thai H; Rangwala S; Gay T; Keating K; McLeod S; Nazarenko I; O'Neil D; Pfister D; Loeffert D
    J Clin Virol; 2009 Jul; 45 Suppl 1():S93-7. PubMed ID: 19651375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the AdvanSure human papillomavirus screening real-time PCR, the Abbott RealTime High Risk human papillomavirus test, and the Hybrid Capture human papillomavirus DNA test for the detection of human papillomavirus.
    Hwang Y; Lee M
    Ann Lab Med; 2012 May; 32(3):201-5. PubMed ID: 22563555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the Anyplex II HPV28 assay with the Hybrid Capture 2 assay for the detection of HPV infection.
    Kwon MJ; Roh KH; Park H; Woo HY
    J Clin Virol; 2014 Apr; 59(4):246-9. PubMed ID: 24568964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative evaluation of three commercial systems for detection of high-risk human papillomavirus in cervical and vaginal ThinPrep PreservCyt samples and correlation with biopsy results.
    Binnicker MJ; Pritt BS; Duresko BJ; Espy MJ; Grys TE; Zarka MA; Kerr SE; Henry MR
    J Clin Microbiol; 2014 Oct; 52(10):3763-8. PubMed ID: 25122861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of clinical performance of Abbott RealTime High Risk HPV test with that of hybrid capture 2 assay in a screening setting.
    Carozzi FM; Burroni E; Bisanzi S; Puliti D; Confortini M; Giorgi Rossi P; Sani C; Scalisi A; Chini F
    J Clin Microbiol; 2011 Apr; 49(4):1446-51. PubMed ID: 21325553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the Abbott RealTime High Risk HPV test and the Roche cobas 4800 HPV test using urine samples.
    Lim MC; Lee DH; Hwang SH; Hwang NR; Lee B; Shin HY; Jun JK; Yoo CW; Lee DO; Seo SS; Park SY; Joo J
    J Virol Methods; 2017 May; 243():74-79. PubMed ID: 28161277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection and genotyping of human papillomavirus by five assays according to cytologic results.
    Choi J; Park Y; Lee EH; Kim S; Kim JH; Kim HS
    J Virol Methods; 2013 Jan; 187(1):79-84. PubMed ID: 22982075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of hybrid capture 2 High-Risk HPV results in the low positive range with cobas® HPV Test results from the ATHENA study.
    Rao A; Sandri MT; Sideri M; Young S; Sharma A; Behrens C
    J Clin Virol; 2013 Sep; 58(1):161-7. PubMed ID: 23895930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the clinical performances of the AdvanSure HPV Screening Real-Time PCR, the Abbott Real-Time High-Risk HPV Test, and the Hybrid Capture High-Risk HPV DNA Test for Cervical Cancer Screening.
    Chung HS; Hahm C; Lee M
    J Virol Methods; 2014 Sep; 205():57-60. PubMed ID: 24814874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the PANArray HPV Genotyping Chip Test with the Cobas 4800 HPV and Hybrid Capture 2 Tests for Detection of HPV in ASCUS Women.
    Ki EY; Lee YK; Lee A; Park JS
    Yonsei Med J; 2018 Jul; 59(5):662-668. PubMed ID: 29869464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the f-HPV typing™ and Hybrid Capture II® assays for detection of high-risk HPV genotypes in cervical samples.
    Cañadas MP; Cirigliano V; Darwich L; Sirera G; Coll J; Clotet B; Videla S
    J Virol Methods; 2012 Jul; 183(1):14-8. PubMed ID: 22449759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transition from Hybrid Capture 2 to Cobas 4800 in Hpv detection: sensitivity and specificity for Cin2+ in two time periods.
    Bottari F; Boveri S; Iacobone AD; Gulmini C; Igidbashian S; Cassatella MC; Landoni F; Sandri MT
    Infect Dis (Lond); 2018 Jul; 50(7):554-559. PubMed ID: 29463149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical performance of Abbott RealTime High Risk HPV test for detection of high-grade cervical intraepithelial neoplasia in women with abnormal cytology.
    Huang S; Erickson B; Tang N; Mak WB; Salituro J; Robinson J; Abravaya K
    J Clin Virol; 2009 Jul; 45 Suppl 1():S19-23. PubMed ID: 19651364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the cobas Human Papillomavirus (HPV) test with the hybrid capture 2 and linear array HPV DNA tests.
    Gage JC; Sadorra M; Lamere BJ; Kail R; Aldrich C; Kinney W; Fetterman B; Lorey T; Schiffman M; Castle PE;
    J Clin Microbiol; 2012 Jan; 50(1):61-5. PubMed ID: 22075592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Abbott RealTime High Risk HPV test: comparative evaluation of analytical specificity and clinical sensitivity for cervical carcinoma and CIN 3 lesions with the Hybrid Capture 2 HPV DNA test.
    Poljak M; Kovanda A; Kocjan BJ; Seme K; Jancar N; Vrtacnik-Bokal E
    Acta Dermatovenerol Alp Pannonica Adriat; 2009 Sep; 18(3):94-103. PubMed ID: 19784522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.